CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-11 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +45,042 | $10.36 | $467K | 117,405 |
| 2025-06-11 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −45,042 | $30.51 | $1.4M | 72,363 |
| 2025-06-11 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −45,042 | 38,928 | ||
| 2025-06-10 | Quart Barry D Director | Option exercise | +8,212 | $3.80 | $31K | 20,758 |
| 2025-06-10 | Quart Barry D Director | Sale | −8,212 | $30.36 | $249K | 12,546 |
| 2025-06-10 | Quart Barry D Director | Option exercise · Share Option | −8,212 | 12,336 | ||
| 2025-06-10 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +15,506 | $10.36 | $161K | 87,869 |
| 2025-06-10 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −15,506 | $30.46 | $472K | 72,363 |
| 2025-06-10 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −15,506 | 83,970 | ||
| 2025-06-09 | Quart Barry D Director | Option exercise | +6,900 | $3.80 | $26K | 19,446 |
| 2025-06-09 | Quart Barry D Director | Sale | −6,900 | $30.26 | $209K | 12,546 |
| 2025-06-09 | Quart Barry D Director | Option exercise · Share Option | −6,900 | 20,548 | ||
| 2025-06-09 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,319 | $10.36 | $107K | 82,682 |
| 2025-06-09 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −10,319 | $30.38 | $313K | 72,363 |
| 2025-06-09 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −10,319 | 99,476 | ||
| 2025-06-05 | Cole G Bradley Director | Option exercise | +3,173 | 12,546 | ||
| 2025-06-05 | Cole G Bradley Director | Option exercise · Restricted Share Units | −3,173 | 0 | ||
| 2025-06-05 | Levy Richard S Director | Option exercise | +3,173 | 17,373 | ||
| 2025-06-05 | Levy Richard S Director | Option exercise · Restricted Share Units | −3,173 | 0 | ||
| 2025-06-05 | Malley Thomas Director | Option exercise | +3,173 | 12,546 |
Page 30 of 74 · 1,467 trades